Resona Asset Management Co. Ltd. Boosts Position in Synopsys, Inc. $SNPS

Resona Asset Management Co. Ltd. increased its position in shares of Synopsys, Inc. (NASDAQ:SNPS) by 16.3% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 62,385 shares of the semiconductor company’s stock after buying an additional 8,758 shares during the period. Resona Asset Management Co. Ltd.’s holdings in Synopsys were worth $30,655,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. Brighton Jones LLC lifted its holdings in shares of Synopsys by 5.7% during the 4th quarter. Brighton Jones LLC now owns 921 shares of the semiconductor company’s stock valued at $447,000 after purchasing an additional 50 shares during the last quarter. Integrated Wealth Concepts LLC grew its stake in Synopsys by 11.6% during the 1st quarter. Integrated Wealth Concepts LLC now owns 760 shares of the semiconductor company’s stock worth $326,000 after buying an additional 79 shares during the last quarter. NewEdge Advisors LLC boosted its holdings in Synopsys by 15.1% in the first quarter. NewEdge Advisors LLC now owns 3,010 shares of the semiconductor company’s stock worth $1,291,000 after acquiring an additional 395 shares in the last quarter. Perigon Wealth Management LLC grew its position in Synopsys by 32.8% during the 2nd quarter. Perigon Wealth Management LLC now owns 2,132 shares of the semiconductor company’s stock worth $1,093,000 after purchasing an additional 527 shares during the last quarter. Finally, Patton Fund Management Inc. purchased a new stake in shares of Synopsys during the second quarter valued at $253,000. Hedge funds and other institutional investors own 85.47% of the company’s stock.

Synopsys Price Performance

Shares of SNPS opened at $501.39 on Friday. The firm has a fifty day moving average price of $466.97 and a 200 day moving average price of $503.94. The stock has a market cap of $95.93 billion, a PE ratio of 62.75, a price-to-earnings-growth ratio of 4.17 and a beta of 1.12. Synopsys, Inc. has a 1-year low of $365.74 and a 1-year high of $651.73. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.62 and a quick ratio of 1.52.

Synopsys (NASDAQ:SNPS) last announced its earnings results on Wednesday, December 10th. The semiconductor company reported $2.90 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.79 by $0.11. The firm had revenue of $2.25 billion during the quarter, compared to analysts’ expectations of $2.25 billion. Synopsys had a return on equity of 7.89% and a net margin of 18.89%.The business’s revenue was up 37.8% on a year-over-year basis. During the same period in the prior year, the firm earned $3.40 EPS. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. As a group, sell-side analysts anticipate that Synopsys, Inc. will post 10.64 EPS for the current year.

Analysts Set New Price Targets

A number of research analysts recently issued reports on SNPS shares. Piper Sandler downgraded shares of Synopsys from an “overweight” rating to a “neutral” rating and decreased their target price for the company from $602.00 to $520.00 in a research report on Tuesday, January 13th. Zacks Research raised shares of Synopsys from a “strong sell” rating to a “hold” rating in a research note on Monday, November 10th. JPMorgan Chase & Co. boosted their price objective on Synopsys from $600.00 to $650.00 and gave the stock an “overweight” rating in a research note on Thursday, December 11th. Needham & Company LLC raised their price target on shares of Synopsys from $550.00 to $580.00 and gave the stock a “buy” rating in a report on Thursday, December 11th. Finally, KeyCorp upped their target price on shares of Synopsys from $575.00 to $600.00 and gave the company an “overweight” rating in a research report on Thursday, December 11th. Nine equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Synopsys currently has an average rating of “Moderate Buy” and a consensus price target of $553.57.

Insider Activity

In other news, insider Janet Lee sold 250 shares of Synopsys stock in a transaction on Monday, January 12th. The stock was sold at an average price of $530.00, for a total transaction of $132,500.00. Following the completion of the transaction, the insider owned 11,959 shares of the company’s stock, valued at $6,338,270. The trade was a 2.05% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CFO Shelagh Glaser sold 3,657 shares of the stock in a transaction on Friday, December 19th. The shares were sold at an average price of $460.77, for a total value of $1,685,035.89. Following the sale, the chief financial officer owned 17,842 shares in the company, valued at approximately $8,221,058.34. This trade represents a 17.01% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 4,157 shares of company stock valued at $1,945,036 over the last three months. 0.62% of the stock is currently owned by corporate insiders.

Synopsys Company Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.